Cardiac Signal Saturation Analysis for Lead Issue Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Implantable medical devices (IMDs) face challenges in reliably detecting medical electrical lead issues, such as insulation breaches or conductor fractures, which can lead to false detection of cardiac arrhythmias and inappropriate therapy delivery.

Innovation Solution

An IMD system that analyzes cardiac electrical signals for saturation events to detect lead issues, comparing these events to predefined criteria to withhold or deliver therapy, ensuring accurate treatment and preventing oversensing of electrical noise.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the IMD delivers therapy based on detected cardiac arrhythmias, then the patient receives treatment for abnormal rhythms, but the system may deliver inappropriate therapy due to false detections caused by lead issues

Engineering Contradiction:
Improvetherapy delivery accuracyVSAvoidfalse arrhythmia detection
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system performs preliminary detection of lead issues by analyzing saturation events in cardiac electrical signals before delivering therapy. This advance detection allows the system to identify lead integrity problems and prevent false arrhythmia detections, ensuring that therapy is only delivered when both arrhythmia and lead integrity are confirmed

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system continuously monitors cardiac electrical signals for saturation events and uses this feedback to assess lead integrity. The feedback mechanism compares detected saturation events against predefined criteria to determine whether lead issues are present, dynamically adjusting therapy delivery decisions based on real-time lead status

Inventive Principle:
Principle #23Feedback

2Measurement precision

If the IMD continuously monitors cardiac signals for arrhythmia detection, then the system can detect abnormal rhythms, but the system may oversense electrical noise due to lead issues

Engineering Contradiction:
Improvearrhythmia detection accuracyVSAvoidelectrical noise oversensing
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The system introduces saturation event analysis as an intermediary check between signal acquisition and arrhythmia detection. By analyzing whether detected events represent true cardiac signals or saturation artifacts, the system filters out electrical noise caused by lead issues while preserving genuine arrhythmia detections

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If the IMD analyzes cardiac signals for lead issue detection, then the system can identify lead integrity problems, but the system complexity increases

Engineering Contradiction:
Improvelead issue detection capabilityVSAvoidsignal analysis complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system uses the existing cardiac electrical signal data to perform self-diagnosis of lead integrity. By analyzing saturation events within the routinely acquired cardiac signals, the system enables lead issue detection without requiring separate diagnostic procedures or additional hardware, maintaining efficiency while enhancing reliability

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS9533165B1Detection of medical electrical lead issues and therapy control
Publication Date: 2017.01.03 MEDTRONIC INC
  • US9533165B1 patent drawing
  • US9533165B1 patent drawing
  • US9533165B1 patent drawing

AI summary

An implantable medical device is configured to detect saturation events from a cardiac electrical signal, detect a tachyarrhythmia based at least in part on the cardiac electrical signal, responsive to detecting the tachyarrhythmia, and compare the detected saturation events to lead issue criteria. If the detected saturation events satisfy lead issue criteria, a therapy for treating the tachyarrhythmia is withheld by the implantable medical device.